Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07209852) titled 'Safety, Performance, and Clinical Benefit of Pacing the Left Bundle Branch Area - Post-Market Clinical Follow-up' on Sept. 29.

Study Type: Observational [Patient Registry]

Primary Sponsor: Boston Scientific Corporation

Condition: Bradycardia Atrioventricular Block Sinus Node Dysfunction Bundle-Branch Block

Intervention: Device: Pacemaker lead

Recruitment Status: Not recruiting

Date of First Enrollment: January 15, 2026

Target Sample Size: 140

To know more, visit https://clinicaltrials.gov/study/NCT07209852

Disclaimer: Curated by HT Syndication....